Malaria

#Drug development #Drug discovery #Malaria #Research

Malaria stopped in its tracks with new drug compound

Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential first of its kind malaria treatment. While drugs and mosquito… Read More

#News

Mosquito
#Clinical trial #Immunology / Virology & Vaccines #Malaria #Research #Vaccines

Malaria vaccine first to achieve WHO-specified 75% efficacy goal

Researchers from the University of Oxford and their partners have reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings (posted on SSRN/Preprints with The Lancet), they note that they are the first to… Read More

#News